Narrow your search

Library

KU Leuven (85)

ULiège (58)

ULB (50)

UCLL (49)

Odisee (47)

Thomas More Kempen (47)

UGent (47)

Thomas More Mechelen (46)

VIVES (46)

LUCA School of Arts (29)

More...

Resource type

book (95)

periodical (18)

dissertation (1)


Language

English (106)

Dutch (3)

French (2)

Russian (1)

Undetermined (1)


Year
From To Submit

2022 (19)

2021 (6)

2020 (1)

2019 (3)

2018 (4)

More...
Listing 1 - 10 of 113 << page
of 12
>>
Sort by

Book
Veterinary pharmacovigilance : adverse reactions to veterinary medicinal products
Author:
ISBN: 9781405169684 Year: 2009 Publisher: Chichester : Wiley-Blackwell,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Miscellanea on encephalopathies
Author:
ISBN: 9535152742 9535104993 Year: 2012 Publisher: IntechOpen

Loading...
Export citation

Choose an application

Bookmark

Abstract

The book project “Miscellanea on Encephalopathies” aims to cover some of the important aspects of infectious-related encephalopathies, post-transplantation and drug-induced encephalopathies, by transmitting valuable information filtered through the real life clinical and research experience of the authors.


Book
Textbook of iatrogenic pathology
Authors: ---
ISBN: 1681085143 9781681085142 Year: 2017 Publisher: Sharjah, United Arab Emirates : Bentham Science Publishers,


Book
Drug-induced diseases : prevention, detection, and management
Authors: --- ---
ISBN: 1585285315 9781585285310 9781585285303 1585285307 Year: 2018 Publisher: Bethesda, MD : American Society of Health-System Pharmacists,

Loading...
Export citation

Choose an application

Bookmark

Abstract

A drug-induced disease is the unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. This book, now a modern classic, examines these unintended effects and creates a knowledge base of potentially causal drugs that must be considered in medication monitoring activities. Now in its third edition, this essential and comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. Edited by James E. Tisdale and Douglas A. Miller.


Book
Pharmacogenetics to Avoid Adverse Drug Reactions
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This book delves into new advances in pharmacogenetics of cardiovascular, cancer, and nervous system drugs. It may be useful for clinicians and patients to understand the basics of pharmacogenetics.

Risk factors for adverse drug reactions-epidemiological approaches
Authors: --- ---
ISBN: 3764323728 0817623728 Year: 1990 Volume: vol 29 Publisher: Basel Boston Birkhäuser


Book
Cardiovascular Safety in Drug Development and Therapeutic Use : New Methodologies and Evolving Regulatory Landscapes
Authors: --- ---
ISBN: 3319403451 3319403478 Year: 2017 Publisher: Cham : Springer International Publishing : Imprint: Adis,

Loading...
Export citation

Choose an application

Bookmark

Abstract

With the advent of multiple new therapeutic agents for a variety of important diseases has come an increasing realization that many of these drugs can have adverse effects on the heart and vascular system. As this book so elegantly details the mechanisms by which harm occurs are highly complex, many times predictable, but always clinically relevant. Notable experts in the field of cardiovascular medicine, such as Drs. Turner, Karnad, and Kothari, have turned their attention to this thorny problem, and begun to dissect the diverse mechanisms by which cardiac harm can occur with a variety of non-cardiac drugs. This is no easy task, given the complexity of the diseases we treat, and the wide spectrum of new therapies we seek to apply. However, it is an issue with which all health care providers must become familiar in order to prescribe appropriate therapy while safeguarding patients against avoidable and life-threatening cardiac adverse effects. This compendium represents the state-of-the-art in the evolving field of cardiac safety and is vital reading for those interested in developing new chemical entities, as well as those who prescribe them and monitor patients for their hazard. As such, I recommend this book as essential reading for students, scientists, and health care providers at all levels of training. Peter R. Kowey, MD, FACC, FAHA, FHRS Lankenau Institute for Medical Research & Thomas Jefferson University.


Book
Safety of Biologics Therapy : Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins
Author:
ISBN: 3319304704 3319304720 Year: 2016 Publisher: Cham : Springer International Publishing : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters.  It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.


Periodical
Bulletin canadien des effets indésirables
Author:
ISSN: 14999471 Year: 2002 Publisher: Ottawa : Santé Canada, Direction des produits de santé commercialisés,


Book
Drug-Induced Lung Injury
Authors: --- ---
ISBN: 981104466X 9811044651 Year: 2018 Publisher: Singapore : Springer Singapore : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases.  Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.

Listing 1 - 10 of 113 << page
of 12
>>
Sort by